FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD
Facultad
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (374)
2024
-
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial
The Lancet, Vol. 403, Núm. 10437, pp. 1649-1659
-
Clinical suspicion, diagnosis and management of cardiac amyloidosis: update and executive summary
Revista Clinica Espanola, Vol. 224, Núm. 5, pp. 288-299
-
Combinational Diuretics in Heart Failure
Current Heart Failure Reports
-
Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response in patients with HER2-positive early breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab
Breast Cancer Research and Treatment
-
Design and baseline characteristics of SALT-HF trial: hypertonic saline therapy in ambulatory heart failure
ESC Heart Failure
-
Invasive Treatment Strategy in Adults With Frailty and Non-ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of a Randomized Clinical Trial
JAMA network open, Vol. 7, Núm. 3, pp. e240809
-
Non-atherosclerotic acute cardiac syndromes: spontaneous coronary artery dissection and Takotsubo syndrome. Comparison of long-term clinical outcomes
Coronary artery disease, Vol. 35, Núm. 1, pp. 50-58
-
Prognosis after heart transplant in patients with hypertrophic and restrictive cardiomyopathy. A nationwide registry analysis
Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 304-313
-
Prognosis of acute heart failure in patients followed up in nursing homes in Spain: Results from the RICA registry
Medicina Clinica, Vol. 162, Núm. 4, pp. 157-162
-
Repetitive ambulatory levosimendan as a bridge to heart transplantation
Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 290-301
-
Review of the allocation criteria for heart transplant in Spain in 2023. SEC-Heart Failure Association/ONT/SECCE consensus document
Revista Espanola de Cardiologia, Vol. 77, Núm. 1, pp. 69-78
-
Risk prediction of major cardiac adverse events and all-cause death following covid-19 hospitalization at one year follow-up: The HOPE-2 score
European Journal of Internal Medicine
-
Sex differences in clinical characteristics and outcomes in the CLOROTIC (combining loop with thiazide diuretics for decompensated heart failure) trial
Revista Clinica Espanola, Vol. 224, Núm. 2, pp. 67-76
-
The significance of metabolic alkalosis on acute decompensated heart failure: the ALCALOTIC study
Clinical Research in Cardiology
-
Use of a surgically implanted, nondischargeable, extracorporeal continuous flow circulatory support system as a bridge to heart transplant
Revista espanola de cardiologia (English ed.), Vol. 77, Núm. 1, pp. 39-49
2023
-
A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study
Respiratory Research, Vol. 24, Núm. 1
-
A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer
Frontiers in Oncology, Vol. 13
-
Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry
American Journal of Cardiovascular Drugs, Vol. 23, Núm. 1, pp. 77-87
-
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer
Annals of Oncology, Vol. 34, Núm. 9, pp. 783-795
-
Benefits of dapagliflozin in the whole spectrum of heart failure in clinical practice: the RICA registry
Future cardiology, Vol. 19, Núm. 6, pp. 323-332